搜索筛选:
搜索耗时0.0830秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Mumtaz A Niazi,Ashaur Azhar,Ka,
来源：世界肝病学杂志：英文版（电子版） 年份：2010
The recommended therapy for chronic hepatitis C (CHC) infection is the combination of a Pegylated interferon and Ribavirin. Almost all such patients on combinat...
[期刊论文] 作者：Hasan Ali,Taqi Rizvi,Mumtaz Niazi,Mark Galan,Nikolaos Pyrsopoulos,
来源：临床与转化肝病杂志（英文版） 年份：2022
We present a unique case of biopsy-proven syphilitic hepa-titis which presented as severe acute liver injury with sig-nificant elevation in aminotransferases and bilirubin, and improved with antibiotic therapy. However, the patient re-turne......
An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence af
[期刊论文] 作者：Nikroo Hashemi,Victor Araya,Kashif Tufail,Laxmi Thummalakunta,Eyob Feyssa,Ashaur Azhar,Mumtaz Niazi,Jorge,
来源：World Journal of Hepatology 年份：2011
AIM: To evaluate the efflicacy and tolerability of an extended treatment protocol and to determine the predictors of sustained virological response (SVR) after...
Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: A case report
[期刊论文] 作者：Mumtaz A Niazi,Ashaur Azhar,Kashif Tufail,Eyob L Feyssa,Stephen F Penny,Marlene McGregory,Victor Araya,
来源：World Journal of Hepatology 年份：2010
The recommended therapy for chronic hepatitis C (CHC) infection is the combination of a Pegylated interferon and Ribavirin. Almost all such patients on combinat...
[期刊论文] 作者：Catherine Choi,Youssef Botros,Jamil Shah,Pei Xue,Anja Jones,Mark Galan,Raquel Olivo,Mumtaz Niazi,Flavio,
来源：临床与转化肝病杂志（英文版） 年份：2020
Direct-acting antiviral (DAA) therapy is often well-tolerated, and adverse events from DAA therapy are uncommon. We report a case of a woman who underwent ortho...
相关搜索：
